Adefovir nephrotoxicity and mitochondrial DNA depletion

被引:16
作者
Bendele, RA [1 ]
Richardson, FC [1 ]
机构
[1] Gilead Sci Inc, Boulder, CO USA
关键词
D O I
10.1053/hupa.2002.124012
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:574 / 574
页数:1
相关论文
共 5 条
[1]   Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study [J].
Benhamou, Y ;
Bochet, M ;
Thibault, V ;
Calvez, V ;
Fievet, MH ;
Vig, P ;
Gibbs, CS ;
Brosgart, C ;
Fry, J ;
Namini, H ;
Katiama, C ;
Poynard, T .
LANCET, 2001, 358 (9283) :718-723
[2]   Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity [J].
Kakuda, TN .
CLINICAL THERAPEUTICS, 2000, 22 (06) :685-708
[3]   Importance of species selection in drug toxicity testing [J].
Morton, DM .
TOXICOLOGY LETTERS, 1998, 103 :545-550
[4]   Toxicity of antiretroviral nucleoside and nucleotide analogues - Is mitochondrial toxicity the only mechanism? [J].
Moyle, G .
DRUG SAFETY, 2000, 23 (06) :467-481
[5]   Mitochondrial toxicity and HIV therapy [J].
White, AJ .
SEXUALLY TRANSMITTED INFECTIONS, 2001, 77 (03) :158-173